NEW YORK (GenomeWeb) – Becton Dickinson reported today that its fiscal second quarter revenues were down 3 percent year over year, reflecting the divestiture of its respiratory solutions business completed in October 2016. On a comparable, currency-neutral basis, Q2 revenues grew 5 percent, BD said.

For the three months ended March 31, BD posted revenues of $2.97 billion compared to $3.07 billion in the year-ago quarter, beating analysts' average estimate of $2.92 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.